-
-
Call more information
660-596-2224 -
A mathematical model developed by researchers at Loyola University in Chicago can predict the length of time patients with hepatitis C virus (HCV) must remain on direct-acting antiviral (DAA) drugs to achieve sustained virologic response, according to a new study. The investigators used early viral kinetic analysis to test study participants—58 people with HCV being […]
Read MoreCollegium announced that the FDA has approved oxycodone (Xtampza ER) extended-release capsules, a twice-daily medication for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. The drug uses Collegium’s proprietary DETERx abuse-deterrent technology platform, and is designed to provide adequate pain control while […]
Read MoreThe routine use of apneic oxygenation during endotracheal intubation of critically ill adults does not necessarily increase oxygen saturation compared with usual care, a recent study has concluded. “Interventions that appear effective in the highly controlled environment of the operating room [OR] frequently fail to translate to critically ill patients in the ICU,” said Matthew […]
Read MoreMany patients undergoing hip or knee replacement are still taking prescription opioid pain medications up to 6 months after surgery, according to a study published in the journal PAIN. Jenna Goesling, PhD, University of Michigan, Ann Arbor, Michigan, and colleagues identified several “red flags” for persistent opioid use — particularly previous use of high-dose opioids. […]
Read MoreA bupivacaine injection along the tract of the nephrostomy site at the time of percutaneous nephrolithotomy (PCNL) reduces postoperative pain as well as the need for narcotic medication, according to study results presented at the 2016 Annual Meeting of the American Urological Association (AUA). Lead author James Mason, MD, University of Florida, Gainesville, Florida, speaking […]
Read More